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1. Introduction  
Tissue plasminogen activator (t-PA) is the gold standard drug for cerebral infarction in the 
acute phase (Adams et al., 2007), but it cannot be administered to all cerebral infarction 
patients. Some patients who survive the acute phase of cerebral infarction suffer from 
permanent hemiparesis in the chronic phase, which highlights the need for regenerative 
medicine to play a more important role in treating such individuals. There are two primary 
approaches to the use of regenerative medicine for patients with cerebral infarction: 
exogenous stem cell therapies, and enhancement of endogenous stem cells.  
Stem cell transplantation is one of the most widely employed strategies using exogenous 
stem cells. Many studies with experimental animals have shown that stem cell 
transplantation enhances functional recovery after cerebral infarction (Kameda et al., 2007; 
Takahashi et al., 2008). Based on the results of animal experiments, several clinical trials for 
patients with cerebral infarction are currently ongoing, using stem cell transplantation 
techniques, typically with mesenchymal stem cells (Detante et al.). However, these clinical 
trials have been started despite a lack of results showing that transplanted stem cells can 
reliably replace infarct areas. The principal purpose of cell transplantation in these cases is 
cell replacement, or replacement and restoration of infarct areas. Nevertheless, only a few 
percent of the transplanted cells typically survive during the chronic phase of cerebral 
infarction (Lindvall & Kokaia, 2006). Even more problematic is the fact that few of these 
transplanted stem cells differentiate into neurons with immunohistological and 
electrophysiological properties (Anderova et al., 2006). Based on these reports, some 
scientists maintain that functional improvements can be achieved without cell-replacement, 
that the effects of trophic factors secreted by the transplanted cells are sufficient (Cabrer et 
al., 2010; Shimada & Spees, 2011).  
Another approach that regenerative medicine can take is enhancement of endogenous stem 
cells, based on methods that are less invasive than the use of exogenous stem cells. Deep 
brain stimulation (DBS) for Parkinson’s disease patients is an example of a standard therapy 
now used in clinical situations. A previous report using animal subjects has shown that DBS 
can enhance the neurogenesis of endogenous stem cells (Toda et al., 2008). Based on this 
report, we evaluated the effectiveness of electrical stimulation on animals with cerebral 
infarction. Recently, we showed that electrical stimulation of the cerebral cortex during the 
acute phase of cerebral infarction exerted anti-apoptotic, angiogenic and anti-inflammatory 
effects through the PI3K-Akt signaling pathway (Baba et al., 2009). Moreover, we showed 
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that striatal electrical stimulation during the chronic phase of cerebral infarction was 
effective due to enhancement of endogenous stem cells in response to glial cell-line derived 
neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF) upregulation 
(Morimoto et al., 2010). Electrical stimulation had therapeutic benefit in cerebral infarction 
cases not only during the acute phase, but also during the chronic phase, which suggests 
that electrical stimulation has considerable therapeutic potential.  
This review summarizes the current consensus concerning regenerative medicine for 
cerebral infarction, focusing on stem cell transplantation and electrical stimulation 
techniques, and briefly describes strategies for applying these methods in a clinical setting. 
2. Approaches to regenerative medicine for cerebral infarction 
2.1 Stem cell transplantation using exogenous stem cells 
2.1.1 Donor cell sources 
Stem cell transplantation is one of the most established strategies based on the use of 
exogenous stem cells. Currently, many different types of stem cell can be cultured and 
transplanted, including induced pluripotent stem cells (iPS cells) (Takahashi & Yamanaka, 
2006), embryonic stem cells (ES cells) (Wang et al., 2011), neural stem cells (NSCs) (Kameda 
et al., 2007; Muraoka et al., 2006) , mesenchymal stem cells (MSCs) (Kurozumi et al., 2004; 
Wang et al., 2010) , and hematopoietic stem cells (Shyu et al., 2006), and some of these have 
already been used in clinical trials. Every type of stem cell has unique advantages and 
disadvantages. Deciding what type of stem cell to transplant requires careful consideration 
of availability, immune system response, ethical concerns, and the possibility of tumor 
genesis. 
Concerning the availability of stem cells for transplantation, iPS and ES cells are the most 
promising candidates, but the possibility of tumor formation must be addressed. Many 
researchers have searched for methods that prevent tumor formation. Regarding iPS cells, 
for example, Maekawa et al. showed that using maternal transcription factor Glis1 instead of 
oncogenic c-Myc enhanced the generation of iPS cells when expressed together with key 
transcription factors Oct3/4, Sox2, and Klf4 (Maekawa et al., 2011). 
The majority of animal experiments have demonstrated the neuroprotective effect of 
transplantation using allografts of adult NSCs or MSCs in the acute phase of ischemia 
(Kameda et al., 2007; Takahashi et al., 2008), but the effectiveness of stem cell transplantation 
during the subacute or chronic phase of ischemia was not seen (de Vasconcelos Dos Santos., 
2011). To avoid the problem of rejection by the immune system, and ethical issues, 
autologous stem cell transplantation using adult NSCs and MSCs is attractive, but 
considerable time is needed to expand these cells so that sufficient quantities are available. 
Muraoka et al. established an autologous NSC transplantation model using adult rats, in 
which NSCs were removed from the subventricular zone of adult Fischer 344 rats using 
stereotactic methods (Muraoka et al., 2008). The NSCs were expanded, which required 
approximately three weeks, and microinjected into normal hippocampus in the autologous 
brain. At the present time, MSCs are considered to be a more useful donor cell source in 
clinical settings than adult NSCs. In Japan, the first clinical trial of autologous MSC 
transplantation was performed for a patient in the chronic phase of cerebral infarction 
(Honmou et al., 2011). Detante et al. have started a clinical Phase II trial using autologous 
MSC transplantation for patients with cerebral infarction, with inclusion criteria that 
patients must have ischemic stroke confirmed by MRI within the previous 14 days. Based on 
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the previous results from animal experiments as well as the current clinical situation, 
autologous stem cell transplantation is considered to be of significant benefit to patients 
who were not administered rt-PA, provided it is performed in the acute phase three hours 
after onset. 
2.1.2 Delivery methods 
There are several stem cell delivery methods, such as intraparenchymal transplantation, 
intravenous administration and intraarterial administration. With any of these methods, the 
number of surviving transplanted donor cells is thought to affect the extent of recovery from 
cerebral infarction. Intraparenchymal transplantation can be performed so that stem cells 
are delivered in the ischemic penumbra, and it is thus the best method for placing the 
largest number of stem cells in the desired area of the brain, but this is the most invasive 
method. Intravenous administration, on the other hand, is the least invasive, but most stem 
cells end up in the liver and lung (Wang et al., 2010), leaving a much smaller number of 
stem cells surviving in the area of the ischemic penumbra compared with the 
intraparenchymal transplantation method. This is why the quantity of stem cells 
administrated intravenously in animal experiments is roughly an order of magnitude larger 
than that used in other delivery methods (Li et al., 2008; Lundberg et al., 2011). Lappalainen 
et al. detected an accumulation of graft cells which were intraarterially administrated in the 
ischemic brain, using SPECT/CT, but such cells were not observed when administrated 
intravenously (Lappalainen et al., 2008). At the present time, relatively few papers have 
explored intraarterial methods of administering stem cells for cerebral infarction in animal 
models. However, an endovascular technique, superselective intraarterial administration to 
the penumbra via a micro-catheter, can be performed in a clinical situation, and this method 
is expected to be less invasive than intraparenchymal transplantation. 
2.1.3 Graft survival 
Although the therapeutic effect of stem cell transplantation depends upon the rate of stem 
cell survival, research to date has reported that only approximately 5% survives after 
transplantation (Lindvall et al., 2004). Cytoprotection can enhance the percentage of graft 
survival. In particular, GDNF has been shown to be an effective neurotropic factor against 
ischemic injury. Its neuroprotective effect mainly derives from activation of the 
phosphatidylinositide-3-kinase/Akt (PI3K/Akt) and mitogen-activated protein kinase/ERK 
(MAPK/ERK) pathways (Nicole et al., 2001; Treanor et al., 1996). During transplantation, 
stem cells are subject to hypoxic-ischemic injury. Wang et al. showed that graft survival was 
enhanced by pretreatment with GDNF for three days before NSC transplantation (Wang et 
al., 2011). Because brain tissue architecture is disrupted in the ischemic brain, the use of 
biodegradable scaffolds may help transplanted stem cells regenerate and/or restore 
damaged brain structures and functions, by affecting cell differentiation, morphology, 
adhesion, or gene expression (Kleinman & Martin, 2005; Steindler, 2002). Jin et al. showed 
that transplantation of human neural precursor cells (NPCs) in Matrigel scaffolding at the 
time of transplantation partially improved therapeutic outcome compared to that of NPCs 
without Matrigel scaffolding, and that the use of NPC/Matrigel cultures dramatically 
improved the therapeutic effect (Jin et al., 2010). These reports indicate that, when using 
transplantation methods employing pre-treatment with GDNF, or Matrigel scaffolding, 
cytoprotective effects that enhance the survival rate of stem cells require time to develop in 
www.intechopen.com
 
Advances in Regenerative Medicine 
 
22
vitro before transplantation and that such development might be related to the enhanced 
cytoprotective effects observed after transplantation. 
2.1.4 Functional recovery mechanisms: cell-replacement versus paracrine effects 
In experiments with animals, many researchers have confirmed that stem cell 
transplantation provides neuroprotective effects immediately after transplantation, based on 
behavioral analyses and histological analyses that show reductions in infarct volume 
(Kameda et al., 2007; Kurozumi et al., 2004; Takahashi et al., 2008). Histological analyses also 
showed that the neuroprotective effects were due to enhanced angiogenesis (Onda et al., 
2008), anti-apoptotic effects (Kameda et al., 2007; Kurozumi et al., 2004), and so on. A recent 
paper showed that mononuclear bone marrow cells played a role in a rapidly developed 
neuroprotective effect by increasing cerebral blood flow six hours after transplantation, 
followed by evidence of angiogenesis (Fujita et al., 2010). Yilmaz et al. described remarkable 
induction of genes for nerve guidance survival (e.g., cytokine receptor-like factor 1, glypican 
1, Dickkopf homolog2, osteopontin), as well as increased expression of neurogenerative, 
nerve guidance, and angiogenic factors (bFGF, bone morphogenetic protein, angiopoietins, 
neural growth factor), after transplantation with bone marrow stromal cells (Yilmaz et al., 
2010). Angiogenesis and anti-apoptotic effects are preferable for neuroprotection, and if the 
goal were limited to functional recovery, these neuroprotective mechanisms might be 
sufficient. However, in a strict sense, stem cell transplantation is expected to provide for cell 
replacement, since stem cells have two outstanding capacities, namely, self-renewal and 
pluripotency, which means that they can produce neurons, astrocytes and oligodendrocytes 
(Gage, 2000; Okano, 2002; Temple, 2001). 
Cell-replacement therapy requires that transplanted stem cells survive in the damaged 
brain, differentiate into mature cells, then replace neurons of several phenotypes, and 
reconstruct new networks with host cells. Several approaches have been studied to enhance 
neuronal differentiation, and one approach is to transplant site-specific cells. If the site-
specific characteristics of NSCs can be maintained during in vitro expansion, such cells may 
differentiate into site-specific neurons after transplantation. Another approach is to modify 
the cellular characteristics of the stem cells differentiation by transfecting a trophic factor 
gene (Kameda et al., 2007; Kurozumi et al., 2004). We have showed that, compared with 
unmodified stem cells, neuronal differentiation is enhanced by transplanting into the 
ischemic brain adult neural stem/progenitor cells that were modified to secrete GDNF. This 
enhancement of the differentiation is usually difficult to detect in the ischemic core, and is 
typically found only in the small ischemic boundary zone. Also, we are still not able to effect 
a complete replacement of the damaged infarct area using transplanted stem cells. 
Liu et al. have shown that DCX-expressing immature neurons in the subventricular zone 
(SVZ) do not exhibit a Na+ current, and their resting membrane potential is approximately  
-25mV in the absence of ischemic insult, however, after ischemic insult, such neurons do 
exhibit a Na+ current, and the membrane potential is hyperpolarized to about -54mV, a 
voltage similar to that of mature neurons. They also showed that gene analysis indicates that 
immature DCX cells express immature markers for Sox 2 and nestin in the absence of 
ischemic insult, but tyrosine hydroxylase (TH) is expressed as a mature marker after 
ischemic insult (Liu et al., 2009). After ischemic insult, immature stem cells become able to 
express the same phenotypes as mature neurons. 
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Research published during the last three years, however, indicates that cell replacement via 
stem cells transplantation is not essential to functional recovery (Ramos-Cabrer et al., 2010; 
Shimada & Spees, 2011). Previously, there was a research trend that aimed specifically at 
developing cell replacement therapies, as many researchers sought better methods to 
improve graft survival rates and enhance neuronal differentiation. Nevertheless, the present 
survival rate for transplanted cells during the chronic phase of cerebral infarction remains in 
the single digits (Lindvall et al., 2004), and few transplanted stem cells differentiate into 
neurons with immunohistological and electrophysiological properties (Anderova et al., 
2006). This has been interpreted by some researchers as indicating that functional 
improvements can be achieved without cell replacement, and that the effects of trophic 
factors secreted by the transplanted cells are sufficient. Ramos-Cabrer et al. recently have 
shown that post-stroke functional recovery after stem cell transplantation is due to paracrine 
mechanisms, not cell replacement. They found no evidence of surviving grafted stem cells 
six months after stem cell transplantation, and, compared with control animals, functional 
recovery was confirmed even during the chronic phase of cerebral infarction (Ramos-Cabrer 
et al., 2010). This report supports a new interpretation concerning the importance of 
paracrine mechanisms to functional recovery from cerebral infarction. Based on this new 
interpretation, clinical trials using stem cells to treat cerebral infarction are presently 
ongoing (Detante et al.). 
2.1.5 Future directions 
An increasing number of research papers on stem cell transplantation are focused on the 
neuroprotective effects provided by paracrine mechanisms (Shimada & Spees, 2011; Sun et 
al., 2010). Although cell replacement therapy is likely to remain an important target of stem 
cell transplantation, the focus on paracrine mechanisms will spur the development of 
clinical trials, for which long-term efficacy and safety are crucial evaluative factors. Thus, 
standardization of techniques will be more important compared with the procedures used 
in animal experiments. Furthermore, it has been reported that the quality of transplanted 
stem cells profoundly affects the functional outcome. Assmus et al. reported the results of 
the REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute 
Myocardial Infarction) trial, and showed that contamination by red blood cells affected the 
functionality of isolated bone marrow-derived progenitor cells, and ultimately inhibited 
recovery from acute myocardial infarction (Assmus et al., 2010). An increasing number of 
clinical trials applying stem cell therapies for cerebral infarction will be started in the near 
future, and cell preparation will play a vital role for proper interpretation of the results.  
2.2 Enhancement of endogenous stem cells 
2.2.1 Long-term potentiation (LTP) 
Another useful approach for regenerative medicine in cerebral infarction cases is to enhance 
endogenous stem cells. LTP is thought to be a cellular and molecular mechanism of 
hippocampal learning and memory (Bliss & Collingridge, 1993). LTP is observed as a long-
lasting enhancement in the efficacy of synaptic transmissions, which requires NMDA 
receptor activation and increased Ca2+ influx. LTP can be induced by brief high-frequency 
stimulation. Chen et al. showed that high-frequency stimulation or tetanic stimulation 
induced the release of Wnt3a from hippocampal neurons (Chen et al., 2006). Wnt3a has been 
shown to be a major regulator of neurogenesis in vivo and in vitro, and blocking Wnt3a 
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expression has been reported to cause a significant decline in neuronal generation 
(Davidson et al., 2007). Moreover, recent papers suggest that LTP per se enhances 
neurogenesis (Bruel-Jungerman et al., 2006; Chun et al., 2006, 2009). These findings, linking 
LTP stimulation to the activation of a large latent neural precursor pool in the dentate gyrus, 
could explain the ability of specific environmental stimuli to increase the rate of 
neurogenesis in the hippocampus over prolonged periods.  
2.2.2 Exercise 
It is now widely accepted that exercise (van Praag et al., 1999), enriched environments 
(Kempermann et al., 1997), and learning tasks (Gould et al., 1999), can enhance the 
neurogenesis of endogenous stem cells, and affect regulatory mechanisms that may be 
linked to LTP. Exercise has been shown to enhance neurogenesis in both intact and disease 
animal models. Tajiri et al. showed that exercise had neuroprotective effects on a 
Parkinson’s disease model in rats, with enhanced neurogenesis and migration toward the 
lesioned striatum observed. Furthermore, brain-derived neurotrophic factor (BDNF) and 
glial cell line-derived neurotrophic factor (GDNF) showed increases in the striatum as a 
consequence of exercise (Tajiri et al., 2010). Li et al. showed that whisker stimulation, as a 
peripheral stimulation after focal barrel cortex ischemia, enhanced migration from the 
subventricular zone, and increased the neurogenesis of endogenous stem cells, due to 
increased vascular endothelial growth factor (VEGF) and stromal-derived factor-1 
expression (SDF-1) in the penumbra. They also showed that local cerebral blood flow 
recovered to a greater degree due to whisker stimulation (Li et al., 2008). This indicates that 
increased peripheral stimulation and afferent signals to the ischemic cortex can activate 
endogenous neural stem cells, cause them to migrate to the injured region, and differentiate 
into mature neurons. Thus, the beneficial aspects of rehabilitation are recognized as being 
vital to long-term recovery from ischemic stroke. 
2.2.3 Electrical stimulation and repetitive transcranial magnetic stimulation 
Electrical stimulation and repetitive transcranial magnetic stimulation have been used in 
clinical situations for treatment of many central nervous system diseases, for example 
Parkinson’s disease (PD) (Fasano et al., 2010), epilepsy (Fisher et al., 2010), depression 
(Horvath et al.,2010) , and chronic pain (Rasche et al., 2006). Deep brain stimulation (DBS) 
has become a standard clinical therapy for PD patients and it can ameliorate motor function 
in such individuals, although the mechanism remains poorly understood. Toda et al. 
showed that DBS of the anterior nucleus of the thalamus (AN) enhanced the presence of 
endogenous stem cells in the hippocampal dentate gyrus and enhanced neurogenesis, which 
were associated with enhanced behavioral performance. Moreover, they showed that DBS of 
the AN reversed steroid-induced reductions in neurogenesis (Toda et al., 2008), implying 
that DBS can modulate synaptic plasticity and hippocampal neurogenesis. 
Based on these reports, we have tried to evaluate whether electrical stimulation has a 
neuroprotective effect that mitigates cerebral infarction damage by the enhancement of 
endogenous stem cells and neurogenesis. We began with epidural stimulation because we 
wanted to stimulate the brain using a method that is less invasive compared with the use of 
exogenous stem cells for stem cell transplantation. In one of our experiments, rats received 
continuous electrical stimulation above the cerebral cortex during the acute phase of 
cerebral infarction. This stimulation increased cerebral blood flow, enhanced behavioral 
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recovery and reduced infarct volume. The neuroprotective effect was derived from anti-
apoptotic, angiogenic and anti-inflammatory effects through the PI3K-Akt signaling 
pathway (Baba et al., 2009). As a next step, we hypothesized that electrical stimulation of the 
striatum could enhance the proliferation, migration, and neuronal differentiation of 
endogenous stem cells in the subventricular zone even during the chronic phase of the 
ischemic brain. Striatal electrical stimulation during the chronic phase of cerebral infarction 
was observed to enhance behavioral recovery and reduce infarct size. This neuroprotective 
effect was derived from stimulation of endogenous angiogenesis and neurogenesis with 
GDNF and VEGF upregulation (Morimoto et al., 2010). Machado et al. showed that chronic 
contralesional electrical stimulation of the lateral cerebellar nucleus improved motor 
recovery in rats following ischemic strokes, an effect derived from increased perilesional 
cortical excitability via chronic activation of the dentatothalamocortical pathway (Machado 
et al., 2009).  
Transcranial direct current stimulation (tDCS) has been used in animal experiments and for 
chronic stroke patients. tDCS is thought to strengthen synaptic connections (Cheeran et al., 
2008; Hummel et al., 2005; Nitsche et al., 2003, 2004), through a mechanism similar to that of 
LTP. Fritsch et al. showed that tDCS improved motor skill learning through enhanced 
synaptic plasticity that required brain-derived neurotrophic factor (BDNF) secretion and 
TrkB activation (Fritsch et al., 2010). 
Vagus nerve stimulation (VNS) has been used in an animal model of ischemia, and patients 
given this therapy have demonstrated enhanced behavioral recovery and reduced infarction 
size (Ay et al., 2009). The potential mechanisms for the observed beneficial effects of VNS 
are thought to be the suppression of increased neuronal excitability, and the reduction of 
cytokine overproduction and inflammation. Collectively, electrical stimulation has been 
shown to have therapeutic benefit in cases of cerebral infarction not only in the acute phase 
but also in the chronic phase, which suggests that electrical stimulation has considerable 
therapeutic potential. 
In addition to electrical stimulation, repetitive transcranial magnetic stimulation (rTMS) has 
been used in animal models of ischemia (Kaga et al., 2003), and in infarct patients with 
aphasia (Weiduschat et al., 2011), and has shown enhanced functional recovery. Compared 
with electrical stimulation, rTMS is more widely used because patients can avoid the 
surgery required for electrode implantation. It is presumed that the mechanism of its 
neuroprotective effect derives from increased glucose metabolism, inhibition of apoptosis in 
the ischemic hemisphere (Gao et al., 2010), and increased expression of c-fos, which is 
followed by upregulation of BDNF (Zhang et al., 2007). 
2.2.4 Rehabilitation combined with electrical stimulation  
Currently, after cerebral infarction, electrical stimulation (especially epidural electrical 
stimulation) is mainly performed together with rehabilitation, to enhance the functional 
recovery that normally occurs during rehabilitation. Northstar Neuroscience has performed 
clinical trials using epidural electrical stimulation for infarct patients with upper extremity 
hemiparesis (Northstar Neuroscience, formerly of Seattle, WA, U.S.A.). Unfortunately, the 
results of a Phase III randomized trial were unsuccessful, but the Phase II study showed that 
this therapeutic intervention is both safe and effective. Recently, preliminary study results 
from the same group showed that patients with non-fluent aphasia benefitted from speech-
language therapy in combination with epidural electrical stimulation of the premotor cortex, 
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identified by fMRI. Patients with moderate as well as severe aphasia showed functional 
improvements after epidural electrical stimulation (Cherney et al., 2010). 
2.2.5 Parameters and stimulation patterns 
As mentioned above, electrical stimulation and transcranial magnetic stimulation can be of 
significant functional benefit to individuals who have suffered a cerebral infarction. 
However, stimulation parameters can vary widely even for the same stimulation method. 
For example, in some of our research on epidural stimulation, we used continuous 
stimulation with 2Hz pulses of 1ms width at an intensity of 100μA. On the other hand, 
Moon et al. used intermittent stimulation with 50Hz pulses of 194ms width whose intensity 
was flexibly adjusted to evoke movement of a forelimb. They also compared the duration of 
stimulation, and observed that compared to continuous stimulation, intermittent 
stimulation enhanced functional recovery more effectively (Moon et al., 2009). 
The neuroprotective and neurorestorative effects of electromagnetic stimulation depend on 
the stimulation parameters and pattern. Moon et al. mentioned that the pattern and 
intensity of stimulation should be modified on an individual basis depending on the extent 
of the infarct. The efficacy of the results is affected by a large number of parameters, such as 
the frequency, intensity, pulse width, and duration of the stimulation (i.e., whether it is 
continuous or intermittent), and the stimulation target area and electrode resistance. Since 
the best combination of stimulation parameters and pattern are unknown at the outset, 
researchers tend to stimulate the ischemic brain using different stimulation parameters and 
patterns, searching for the combination that best enhances the neuroprotective and 
neurorestorative effects. 
Regarding the frequency of stimulation, the difference in effect between high-frequency 
stimulation and low-frequency stimulation is usually explained as a consequence of 
different cellular and molecular mechanisms, LTP versus long-term depression (LTD), 
because synaptic plasticity is one of the mechanisms responsible for enhanced functional 
recovery due to electrical stimulation. Based on numerous previous reports, brief high-
frequency stimulation (100Hz or higher) can induce long-term potentiation (LTP). On the 
other hand, brief low-frequency stimulation (1 or 2Hz) can induce long-term depression 
(LTD), which impairs long-lasting enhancement of synaptic transmission. Thus, the 
mechanism of enhanced recovery observed in response to high-frequency stimulation is 
discussed in terms of LTP, whereas low-frequency stimulation fails to induce functional 
recovery. 
The duration of stimulation also affects the outcome. Brief high-frequency stimulation 
induces LTP, but this does not mean that continuous high-frequency stimulation will do the 
same. In a preliminary study, we could not confirm reductions in infarction volume after 
continuous high-frequency stimulation, compared with application of low-frequency 
stimulation (Baba et al., 2009). This implies that inappropriate parameters and stimulation 
patterns may simply cause tissue damage, and provide no therapeutic effect. 
The condition of the brain also affects the results. Most LTP experiments conducted in the 
field of electrophysiological research are performed using intact rats and mice. As described 
above, NMDA receptor activation and increased Ca2+ influx are required for the induction 
of LTP. Increased Ca2+ influx is also observed in ischemia and because the ischemic brain 
has already been exposed to increased Ca2+ influx, the response to high-frequency 
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stimulation that can induce LTP in intact animals would be different in animals with 
cerebral infarction.  
Although LTP is a possible mechanism whereby electrical stimulation enhances functional 
recovery, it is likely that other mechanisms are also involved. Electrical stimulation can 
induce increased regional cerebral blood flow, suppress inflammatory responses, induce 
anti-apoptotic responses, and enhance angiogenesis, which, individually and in 
combination, modulate the microenvironment of the infarct brain to enable functional 
recovery. This implies that electrical stimulation should be performed using appropriate 
parameters and stimulation patterns that are tailored for the condition of the brain. 
2.2.6 Future directions 
Due to a recent finding, that aged mice contain a larger pool of latent stem cells than can be 
activated (Walker et al., 2008), determining the best parameter settings and pattern of 
electromagnetic stimulation that will yield the best possible functional outcomes in patients 
with cerebral infarction is of paramount importance. To find ideal parameter values and 
patterns, the mechanism of electrical and magnetic stimulation must be elucidated in more 
detail. Given the failure of the Northstar Neuroscience Phase III trial in which epidural 
electric stimulation was used, rTMS will likely play a more important role for cerebral 
infarction patients in the future, because it is a less invasive technique. And, although 
improving cerebral infarction treatment procedures is of vital importance, primary stroke 
prevention is also essential. Simvastatin enhances hippocampal LTP in mice and causes a 
significant increase in Akt phosphorylation (Mans et al., 2010), and since LTP per se can 
enhance neurogenesis, as mentioned earlier, this medication should be effective for 
preventing primary stroke as well as hyperlipidemia. In short, the protection and 
enhancement of endogenous stem cells may be a key factor in the maintenance and 
prolongation of health.  
2.3 Progress in ischemia analysis methods 
Thus far, we have outlined basic therapeutic strategies for treating cerebral ischemia, based 
on the use of exogenous stem cells and the enhancement of endogenous stem cells. 
Improvement in therapeutic strategies and further elucidation of the ischemia mechanism in 
greater detail are both important. 
To elucidate the mechanism of ischemia, and the actions of regenerative medicine, we need 
to analyze the neuronal activity in the ischemic brain by examining the response of single 
cells, as well as the response of large populations of neurons. For this purpose, the 
combination of MRI examinations (especially fMRI) and electrophysiological analysis are 
useful, because fMRI signals are thought to be proportional to the local average of neuronal 
activity. 
The use of fMRI provides a major breakthrough not only in animal experiments but also in 
treatment of patients. As mentioned above, fMRI enables the enhancement of patient 
rehabilitation after stroke, via epidural electrical stimulation and detection of premotor 
cortex function. Using fMRI techniques, functional recovery after ischemia can be 
monitored, as originally functional areas are reactivated, with preservation of neurovascular 
coupling (Weber et al., 2008). fMRI also can reveal ipsilateral cortical fMRI responses after 
peripheral nerve damage, so that increased interneuron activity can be observed. Thus, 
fMRI enables analysis of modifications in fiber connections, such as callosal 
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interhemispheric projections (Pelled et al., 2009). The use of voltage-sensitive dyes also 
provides a similar correlation with extracellular direct current potential recording, which 
enables the analysis of molecular mechanisms of ischemia from an electrophysiological 
point of view (Farkas et al., 2008). Voltage-sensitive dye techniques allow sensory-evoked 
depolarization after cerebral infarction to be analyzed in considerable detail (Siglera et al., 
2009). 
The comparison of results derived from MRI examinations with those obtained from 
electrophysiological analysis would also be useful. The ischemic penumbra is a major target 
when attempting to treat cerebral infarction. From an electrophysiological point of view, 
depolarization is induced in the ischemic core and brief depolarization is induced in peri-
infarct areas. Unlike electrophysiological analysis, diffusion-weighted imaging (DWI) in 
MRI does not include peri-infarct areas, defined as areas where a brief depolarization is seen 
during an electrophysiological examination. Thus, electrophysiological analysis can detect 
wider areas of damage than those detectable using histological or MRI techniques (Breschi 
et al., 2010). Behavioral analysis and fMRI analysis are typically usually used when 
analyzing and evaluating functional recovery, but electrophysiological analysis is seldom 
performed. The pursuit of cross-sectional analysis in greater depth should help to clarify the 
mechanism of cerebral infarction. 
3. Conclusion 
We have reviewed the therapeutic effect of stem cell transplantation and techniques for the 
enhancement of endogenous stem cells. As described above, previous studies have shown 
that functional recovery after cerebral infarction can be enhanced by stem cell 
transplantation, and that electromagnetic stimulation can provide neuroprotective and/or 
neurorestorative effects in animal models of ischemia. These results will stimulate 
additional clinical studies, but the development of more effective and reliable therapies will 
require further analysis. 
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